Michael E. Kamarck

President, WYETH.

Companies

Vaxcyte, Inc.Board member Oct 29, 2021 to Jun 15, 2023¹
Passage BIO, Inc.Board member Jul 6, 2022 to May 26, 2023²
Trillium Therapeutics Inc.Board member Jan 4, 2021 to Nov 19, 2021³
VIR BiotechnologyChief Technology Officer Oct 10, 2019 to Oct 10, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vaxcyte, Inc. PCVX5,625 shares⁵$366.9K at $65.22Jun 13, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 13, 2023Granted 2,500 shares of Vaxcyte, Inc.⁵
Jun 1, 2022Granted 3,125 shares of Vaxcyte, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVaxcyte, Inc., Board member
2
SEC EDGARPassage BIO, Inc., Board member
3
SEC EDGARTrillium Therapeutics Inc., Board member
4
SEC EDGARVIR Biotechnology, Chief Technology Officer
5
SEC EDGARVaxcyte, Inc. shares after the filing of Jun 13, 2023
6
SEC EDGARForm 4 filed Jun 3, 2022